Biotech · Private company · Chicago, IL, US
Chicago Biosolutions, Inc.
Track this companyFree. Adds Chicago Biosolutions, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Development of 4-(aroylamino)piperidine-based entry inhibitors as anti-influenza therapeuticsFiscal year 2024 · $999.2KNIH RePORTER 5R42AI155039-04 · fetched Nov 12, 2026